Noxopharm (ASX:NOX) raises $8.1M to further VeyondaNoxopharm...

  1. 471 Posts.
    lightbulb Created with Sketch. 34

    Noxopharm (ASX:NOX) raises $8.1M to further Veyonda



    • Noxopharm (NOX) has announced an $8.1 million capital raising to advance Veyonda, its late-stage cancer treatment drug
    • In addition, the funds will allow Noxopharm to buy back and terminate over $4 million worth of convertible notes
    • The capital raising will include a $3.1 million equity placement through the issue of shares at a price of 18 cents each

    Click to view full article

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
9.8¢
Change
0.000(0.00%)
Mkt cap ! $28.63M
Open High Low Value Volume
9.7¢ 9.8¢ 9.5¢ $15.43K 159.9K

Buyers (Bids)

No. Vol. Price($)
1 47773 9.3¢
 

Sellers (Offers)

Price($) Vol. No.
9.8¢ 47899 1
View Market Depth
Last trade - 16.10pm 12/09/2025 (20 minute delay) ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.